These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10410743)

  • 1. Rare and unusual parkinsonian syndromes.
    Wszolek ZK; Koller WC
    Adv Neurol; 1999; 80():369-76. PubMed ID: 10410743
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of parkinsonian syndromes with L-dopa. Results and prospects].
    Fazio C
    Sist Nerv; 1970; 22(2):61-6. PubMed ID: 5504558
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic and environmental factors in the pathogenesis of Parkinson's disease.
    Mizuno Y; Shimoda-Matsubayashi S; Matsumine H; Morikawa N; Hattori N; Kondo T
    Adv Neurol; 1999; 80():171-9. PubMed ID: 10410718
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative biochemical studies in organic parkinsonian syndromes and drug induced parkinsonian syndromes].
    Bruck H; Gerstenbrand F; Gnad H; Gründig E; Prosenz P
    Psychiatr Neurol (Basel); 1966; 151(2):81-7. PubMed ID: 4381177
    [No Abstract]   [Full Text] [Related]  

  • 5. [Conference at the Salpêtrierère. 1996 March. Parkinsonian syndrome, hallucinations and dementia in a 70-year-old woman].
    Gil R; Créange A; Degos JD; Adle-Biassette H; Gray F
    Rev Neurol (Paris); 1997 Jul; 153(6-7):440-7. PubMed ID: 9684015
    [No Abstract]   [Full Text] [Related]  

  • 6. The diagnosis of Parkinsonism or Parkinson syndrome.
    McDowell FH
    Contemp Neurol Ser; 1971; 8():163-74. PubMed ID: 5162179
    [No Abstract]   [Full Text] [Related]  

  • 7. The Parkinson's complex: parkinsonism is just the tip of the iceberg.
    Langston JW
    Ann Neurol; 2006 Apr; 59(4):591-6. PubMed ID: 16566021
    [No Abstract]   [Full Text] [Related]  

  • 8. Speculations on the etiology of Parkinson's disease.
    Calne DB; Duvoisin RC; McGeer E
    Adv Neurol; 1984; 40():353-60. PubMed ID: 6695611
    [No Abstract]   [Full Text] [Related]  

  • 9. Temporary deterioration in parkinsonian signs after modest alcohol intake.
    Fernandez W; Lees AJ
    Mov Disord; 1992; 7(3):284-5. PubMed ID: 1620149
    [No Abstract]   [Full Text] [Related]  

  • 10. [Parkinson-plus-syndromes].
    Nacimiento W
    Fortschr Neurol Psychiatr; 2006 Mar; 74(3):165-78; quiz 179-80. PubMed ID: 16528643
    [No Abstract]   [Full Text] [Related]  

  • 11. Parkinsonian syndromes.
    Paulson GW; Aotsuka A
    Semin Neurol; 1993 Dec; 13(4):359-64. PubMed ID: 8146486
    [No Abstract]   [Full Text] [Related]  

  • 12. Pesticide-Parkinson link explored.
    Bonetta L
    Nat Med; 2002 Oct; 8(10):1050. PubMed ID: 12357226
    [No Abstract]   [Full Text] [Related]  

  • 13. Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.
    Sun F; Kanthasamy A; Anantharam V; Kanthasamy AG
    Pharmacol Ther; 2007 Jun; 114(3):327-44. PubMed ID: 17521740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Parkinson's disease: new clues to the etiology].
    Braham J
    Harefuah; 1985 Aug; 108(3-4):103-4. PubMed ID: 4076870
    [No Abstract]   [Full Text] [Related]  

  • 15. The MPTP model of Parkinson's disease.
    Smeyne RJ; Jackson-Lewis V
    Brain Res Mol Brain Res; 2005 Mar; 134(1):57-66. PubMed ID: 15790530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental models of Parkinson's disease: insights from many models.
    Tolwani RJ; Jakowec MW; Petzinger GM; Green S; Waggie K
    Lab Anim Sci; 1999 Aug; 49(4):363-71. PubMed ID: 10480640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications.
    Chase TN; Oh JD
    Ann Neurol; 2000 Apr; 47(4 Suppl 1):S122-9; discussion S129-30. PubMed ID: 10762139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Parkinsonism and epilepsy].
    Oliveras Ley C; Pujadas Navines F
    Neurologia; 1986; 1(2):89. PubMed ID: 3274639
    [No Abstract]   [Full Text] [Related]  

  • 19. Cognitive and behavioral changes in the Parkinson-plus syndromes.
    Cohen S; Freedman M
    Adv Neurol; 2005; 96():166-86. PubMed ID: 16383219
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of mitochondria in Parkinson disease.
    Kösel S; Hofhaus G; Maassen A; Vieregge P; Graeber MB
    Biol Chem; 1999; 380(7-8):865-70. PubMed ID: 10494835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.